Stoic VC
Venture capitalSydney Β· Pre-SeedβSeed Β· 5 people tracked
Investment thesis
Stoic partners with researchers to transform scientific breakthroughs into commercially viable products. The firm has access to Australia's top 10 research institutions through partnerships with Australia's first university fund since 2019, and benefits from capital provided by Unisuper, a leading superannuation fund. The investment focus spans human health innovations, next-generation computing systems, and solutions to environmental challenges. The firm seeks founders at the proof-of-concept stage who can rapidly translate research into market-ready technologies.
Source: firm website, verified Jul 21, 2026.
Team Β· 5 people
from the firm's websiteManaging partner with over 20 years of experience founding and investing in life sciences companies. Was an early investor in Cleanspace, Resapp (acquired by Pfizer), and Cap-XX. Formerly a business school professor at UCLA, Emory, and HKUST, and has consulted for major strategy firms including McKinsey, BCG, and Bain. Holds a PhD in Economics and Strategy from UCLA.
Co-founder and general partner with over 20 years of startup and early-stage venture investment experience. Previously established Macquarie PRISM, a $3β30 million funding vehicle, and led Macquarie's Private Bank for 12 years before co-founding life sciences and deep tech venture firm Co-Collective in 2014.
Partner at Stoic VC who founded a telehealth startup in 2019 before transitioning to venture capital. Has served on investment committees at Uniseed, Antler, and the NSW Government's Emerging Technology Commercialisation Fund, and is an angel investor in several life science and deep tech ventures. Holds a degree in Neuroscience and Finance from the University of Sydney.
Venture partner and former CEO of Uniseed with nearly two decades of board and executive experience in commercializing early-stage technologies. Has served on boards of startups that collectively raised over AU$300 million, with notable exits including Fibrotech to Shire, Spinifex to Novartis, and Kinoxis' license agreement with Boehringer Ingelheim. Recognized in the 2018 GUV Powerlist as a top global figure in university venturing.
Chief Financial Officer at Stoic VC with over 16 years of fund administration experience spanning compliance, valuations, and reporting. Plays a central operational role in the firm's investment process and is focused on process improvement and operational excellence.
Investments Β· 34 tracked
founders shown can be your intro pathPreventing airborne diseases in agriculture with cutting-edge technology that helps farmers proactively manage crops.
Cardiovascular disease improvement solutions
Universal nasal spray for viral respiratory infections.
Vision loss treatment solutions
Precision cancer treatment technology
Developing next generation therapeutics for behavioural and cognitive disorders.
New addiction and behavioral therapy platform partnered with Boehringer
Smart prevention and patient monitoring solution for pressure ulcers
Personalised brain stimulation to boost focus and cognitive function.
Therapies for fibrotic and inflammatory diseases associated with diabetes complications
Targeted release probiotic drink
Blood collection tube technology
Frequently asked questions
- What stage does Stoic VC invest at?
- Stoic VC invests at the Pre-Seed, Seed stages.
- What is Stoic VC's typical check size?
- Stoic VC typically writes checks of $100K β $1M.
- What sectors does Stoic VC focus on?
- Stoic VC focuses on AgTech, AI & Machine Learning, Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is Stoic VC located?
- Stoic VC is headquartered in Sydney, AU.
- Does Stoic VC lead rounds?
- Stoic VC typically participates in rounds rather than leading them.
Similar investors
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Everywhere Ventures is an early-stage venture capital firm that backs founders across all sectors and geographies. The firm invests in pre-seed and seed stage companies and is known for providing high-value support to founders through its active investor community of LPs who are themselves founders and operators.
A Silicon Valley venture capital firm focused on investing in early-stage Korean and Asian technology startups expanding into global markets. The firm specializes in cross-border expansion, GTM strategy, fundraising, executive recruitment, and mentoring.
1955 Capital invests in early-stage companies emerging from scientific breakthroughs in biology, materials, and computation. The firm focuses on translating foundational science into scalable commercial enterprises, partnering closely with founders and scientists from discovery through growth.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.